Alex Lebeaut
Pharmaceutical Sciences
Calypso Biotech
Switzerland
Biography
He brings significant medical and scientific knowledge to Calypso Biotech SA, with more than 20 years of broad experience working with pharmaceutical and biotech companies, especially in gastroenterology.​​ He is currently Senior Vice-President, Head of Global Drug Development with IPSEN Biopharmaceuticals (NJ, USA). He has previously held senior leadership medical responsibilities with Bluebird bio (Cambridge, MA), Axcan Pharmaceuticals (Quebec, Canada and Bridgewater, NJ), Sanofi (Bridgewater, NJ), Novartis Pharmaceuticals (East Hanover, NJ and Basel, Switzerland) and Schering-Plough Research Institute (Kenilworth, NJ). Dr. LeBeaut earned his MD and University Diploma in AIDS & other retroviruses infections from the University of Paris VII and received a post graduate diploma specialized in pediatrics from the University of Paris V.original articles and reviews.
Research Interest
Pharmaceutical Sciences
